Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 143-152

  Graziosi, Luigina ^a   Mencarelli, Andrea ^b   Santorelli, Chiara ^a   Renga, Barbara ^b   Cipriani, Sabrina ^b   Cavazzoni, Emanuel ^a   Palladino, Giuseppe ^b   Laufer, Stefan ^c   Burnet, Michael ^d   Donini, Annibale ^a   Fiorucci, Stefano ^b  

^a Nuova Facoltà di Medicina e Chirurgia   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Synovo GmbH   (Germany)

Author keywords

Gastric cancer; ML3403; p38 MAPK; Peritoneal dissemination

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTINEOPLASTIC AGENT; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE P38; ML 3403; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SENSITIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HUMANS; IMIDAZOLES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED NOD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERITONEAL NEOPLASMS; PHOSPHOPROTEINS; PROTEIN KINASE INHIBITORS; PYRIDINES; STOMACH NEOPLASMS;

EID: 84855533355     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.015     Document Type: Article

References (37)

1. Atsumi, T., Kato, K., Uno, K., Iijima, K., Koike, T., Imatani, A., Ohara, S., Shimosegawa, T., 2007. Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer. Pathol. Int. 57, 635-644. (Pubitemid 47353039)
2. Boukerche, H., Su, Z.Z., Emdad, L., Baril, P., Balme, B., Thomas, L., Randolph, A., Valerie, K., Sarkar, D., Fisher, P.B., 2005.mda 9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res. 65, 10901-10911. (Pubitemid 41713358)
3. Boukerche, H., Aissaoui, H., Prevost, C., Hirbec, H., Das, S.K., Su, Z.Z., Sarkar, D., Fisher, P.B., 2010. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-Kb. Oncogene 29, 3054-3066.
4. Boulikas, T., Vougiouka, M., 2003. Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 10, 1663-1682.
5. Costea, D.E., Kulasekara, K., Neppelberg, E., Johannessen, A.C., Vintermyr, O.K., 2006. Species-specific fibroblasts required for triggering invasiveness of partially transformed oral keratinocytes. Am. J. Pathol. 168, 1889-1897. (Pubitemid 43825309)
6. Cuadrado, A., Nebreda, A.R., 2010. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417.
7. Dicken, B.J., Bigam, D.L., Cass, C., Mackey, J.R., Joy, A.A., Hamilton, S.M., 2005. Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg. 241, 27-39. (Pubitemid 40044837)
8. Guo, X., Ma, N., Wang, J., Song, J., Bu, X., Cheng, Y., Sun, K., Xiong, H., Jiang, G., Zhang, B., Wu, M., Wei, L., 2008. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer 8, 375.
9. Huang, S., New, L., Pan, Z., Han, J., Nemerow, G.R., 2000. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells require constitutive p38 alpha mitogen-activated protein kinase activity. J. Biol. Chem. 275, 12266-12272. (Pubitemid 30237807)
10. Ingold, B., Simon, E., Ungethüm, U., Kuban, R.J., Müller, B.M., Lupp, A., Neumann, U., Ebert, M.P., Denkert, C., Weichert, W., Schulz, S., Röcken, C., 2010. Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer? PLoS One 5, e10087.
11. Ito, Y., Sasaki, Y., Horimoto, M., Wada, S., Tanaka, Y., Kasahara, A., Ueki, T., Hirano, T., Yamamoto, H., Fujimoto, J., Okamoto, E., Hayashi, N., Hori, M., 1998. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27, 951-998.
12. Junttila, M.R., Ala-aho, R., Jokilehto, T., Peltonen, J., Kallajoki, M., Grenman, R., Jaakkola, P., Westermarck, J., Kähäri, V.M., 2007. p38a and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 26, 5267-5279. (Pubitemid 47237627)
13. Jüttner, S., Wissmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P.M., Kemmner, W., Höcker, M., 2006. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J. Clin. Oncol. 24, 228-240. (Pubitemid 46622052)
14. Karcher, S.C., Laufer, S.A., 2009. Successful structure-based design of recent p38 MAP kinase inhibitors. Curr. Top. Med. Chem. 9, 655-676.
15. Kelland, L., 2007. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573-584. (Pubitemid 47106628)
16. Korenaga, D., Orita, H., Maekawa, S., Itasaka, H., Ikeda, T., Sugimachi, K., 1998. Peritoneal collagen type IV concentration in adenocarcinoma of the gastrointestinal tract and its relationship to histological differentiation, metastasis, and survival. Surg. Today 28, 780-786. (Pubitemid 28374391)
17. Larive, R.M., Urbach, S., Poncet, J., Jouin, P., Mascré, G., Sahuquet, A., Mangeat, P.H., Coopman, P.J., Bettache, N., 2009. Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion. Oncogene 28, 2337-2347.
18. Laufer, S.A., Margutti, S., 2008. Isoxazolone based inhibitors of p38 MAP kinases. J. Med. Chem. 51, 2580-2584. (Pubitemid 351628521)
19. Leav, I., Galluzzi, C.M., Ziar, J., Stork, P.J., Ho, S.M., Loda, M., 1996. Mitogen activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone induced prostatic dysplasia and carcinoma. Lab. Invest. 75, 361-370. (Pubitemid 26314521)
20. Miki, H., Yamada, H., Mitamura, K., 1999. Involement of p38 MAP kinase in apoptotic and proliferative alteration in human colorectal cancers. Anticancer Res. 19, 5283-5291. (Pubitemid 30103363)
21. Nakashima, H., Natsugoe, S., Ishigami, S., Okumura, H., Matsumoto, M., Hokita, S., Aikou, T., 2006. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett. 236, 89-94.
22. Ni, X.F., Wu, C.P., Jiang, J.T., 2010. Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX. World J. Gastroenterol. 16, 2163-2169.
23. Olson, J.M., Hallahan, A.R., 2004. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol. Med. 10, 125-129. (Pubitemid 38293348)
24. Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Richardson, A.L., Weinberg, R.A., 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348. (Pubitemid 40692295)
25. Riccaboni, M., Bianchi, I., Petrillo, P., 2010. Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov. Today 15, 517-530.
26. Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., Becker, K.F., 2002. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 161, 1881-1891. (Pubitemid 35265545)
27. Salh, B., Marotta, A., Matthewson, C., Ahluwalia, M., Flint, J., Owen, D., Pelech, S., 1999. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer. Anticancer Res. 19, 731-740. (Pubitemid 29168324)
28. Sasaki, T., Maeda, Y., Kobayashi, T., Okamoto, R., Omuro, Y., Takada, N., 2000. Standard chemotherapy for gastrointestinal malignancies based on evidence. Jpn. J. Cancer Chemother. 27, 166-176.
29. Schimanski, C.C., Galle, P.R., Moehler, M., 2008. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World J. Gastroenterol. 14, 4721-4724.
30. Schmalhofer, O., Brabletz, S., Brabletz, T., 2009. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28, 151-166.
31. Stacker, S.A., Achen, M.G., Jussila, L., Baldwin, M.E., Alitalo, K., 2002. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2, 573-583. (Pubitemid 37328924)
32. Su, J.L., Yang, P.C., Shih, J.Y., Yang, C.Y., Wei, L.H., Hsieh, C.Y., Chou, C.H., Jeng, Y.M., Wang, M.Y., Chang, K.J., Hung, M.C., Kuo, M.L., 2006. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9, 209-223.
33. Ulanova, M., Puttagunta, L., Marcet-Palacios, M., Duszyk, M., Steinhoff, U., Duta, F., Kim, M.K., Indik, Z.K., Schreiber, A.D., Befus, A.D., 2005. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L497-L507. (Pubitemid 40229515)
34. Wagner, E.F., Nebreda, A.R., 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549.
35. Yasumoto, K., Koizumi, K., Kawashima, A., Saitoh, Y., Arita, Y., Shinohara, K., Minami, T., Nakayama, T., Sakurai, H., Takahashi, Y., Yoshie, O., Saiki, I., 2006. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66, 2181-2187.
36. Yokozaki, H., 2007. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol. Int. 50, 767-777.
37. Yonemura, Y., Bando, E., Kawamura, T., Ito, H., Endo, Y., Miura, M., Kiyosaki, K., Sasaki, T., 2007. Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat. Res. 134, 357-373.